BCV
TENX icon

Banque Cantonale Vaudoise’s Tenax Therapeutics TENX Stock Holding History

Banque Cantonale Vaudoise’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1
Closed – – 1077
2023
Q4 		$0 Hold
1
– – ﹤0.01% 1186
2023
Q3 		$0 Hold
1
– – ﹤0.01% 1211
2023
Q2 		$0 Buy
+1
New +$27 ﹤0.01% 1228
2023
Q1 		– Sell
-1
Closed – – 1224
2022
Q4 		$0 Hold
1
– – ﹤0.01% 1243
2022
Q3 		$0 Hold
1
– – ﹤0.01% 1288
2022
Q2 		$0 Hold
1
– – ﹤0.01% 1355
2022
Q1 		$1K Hold
1
– – ﹤0.01% 1292
2021
Q4 		$1K Hold
1
– – ﹤0.01% 1320
2021
Q3 		$2K Hold
1
– – ﹤0.01% 1263
2021
Q2 		$2K Hold
1
– – ﹤0.01% 1230
2021
Q1 		$2K Hold
1
– – ﹤0.01% 1137
2020
Q4 		$2K Hold
1
– – ﹤0.01% 1062
2020
Q3 		$2K Buy
+1
New +$2.13K ﹤0.01% 1044

Other funds holding TENX

Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
AF
Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return
TAM
Tucker Asset Management Littleton, Colorado $343M AUM 17.55% 1-Year Est. Return

Banque Cantonale Vaudoise's TENX Position: Q1 2024 in Review

Banque Cantonale Vaudoise sold out of Tenax Therapeutics (TENX) in Q1 2024, closing a stake of 1 share.

Banque Cantonale Vaudoise first reported a position in TENX in Q3 2020 and held it in 13 quarters. The position peaked at $2K in Q3 2021. 9 funds tracked by Wall St. Rank hold TENX as of Q1 2024.

  • Banque Cantonale Vaudoise reported no remaining Tenax Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Banque Cantonale Vaudoise sold 1 Tenax Therapeutics share in Q1 2024.
  • Banque Cantonale Vaudoise first reported a position in Tenax Therapeutics in Q3 2020 and held it in 13 quarters.
  • Banque Cantonale Vaudoise's Tenax Therapeutics position peaked at $2K in Q3 2021.
  • 9 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q1 2024.

Based on Banque Cantonale Vaudoise's 13F filing for Q1 2024, filed 10 Apr 2024.